Rheumatology Research Program
Research conducted by the Division of Rheumatology improves quality and outcomes for children who live with autoimmune and autoinflammatory disorders though new ways to diagnosis and treat many of these conditions, including juvenile dermatomyositis, juvenile scleroderma, systemic lupus erythematosus, childhood onset arthritis, vasculitis, and juvenile idiopathic arthritis. Research interests are focused on patient-reported outcomes, measures of disease activity and remission, biomarkers of disease activity, disease management, and drug trials. The division’s physicians participate in national multicenter research coordinated through the Childhood Arthritis and Rheumatology Research Alliance, which focuses on disease management, and the Pediatric Rheumatology Collaborative Study Group, which concentrates on drug trials. The Division of Rheumatology provides opportunities for participation in clinical research through designated subspecialty clinics, including its Cure JM Center of Excellence. The division provides specialty and research-focused clinics in childhood lupus, musculoskeletal ultrasound, autoimmune encephalitis and related diseases, immune dysregulation, and chronic noninfectious osteomyelitis as well as organ-specific combined clinics with dermatology, nephrology, and neurology. Learn more about the Rheumatology Research Program.